4.7 Editorial Material

NADPH Oxidases: Molecular Understanding Finally Reaching the Clinical Level?

期刊

ANTIOXIDANTS & REDOX SIGNALING
卷 11, 期 10, 页码 2365-2370

出版社

MARY ANN LIEBERT, INC
DOI: 10.1089/ars.2009.2615

关键词

-

资金

  1. NHLBI NIH HHS [R37 HL038206, R01 HL058863, R01 HL058863-11, P01 HL075209-050001, R37 HL038206-23, P01 HL075209] Funding Source: Medline
  2. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075209, R37HL038206, R01HL058863] Funding Source: NIH RePORTER

向作者/读者索取更多资源

NADPH oxidases (Nox) have been the subject of very intensive research over the past several years, which has led to in-depth understanding of the function of these enzymes in health and disease. Discovery of novel Nox enzymes and identification of a very wide range of tissue expression has increased our understanding of how NADPH oxidases may regulate so many distinct cellular functions and how the dysfunction of these enzymes may lead to disease. The present Forum issue summarizes the most novel aspects of NADPH oxidase biology, focusing on linking the molecular basis of NADPH oxidase function, compartmentalization, and differential expression patterns to diseases such as those of the pulmonary system, inflammation, central nervous system disorders, endothelial and vascular dysfunction, as well as disorders involving angiogenesis and stem cell and endothelial progenitor cell functions. Establishing these links may be the first step for future therapeutic use of NADPH oxidase inhibitors, which are discussed at length within this Forum issue. Antioxid. Redox Signal. 11, 2365-2370.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据